We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nocturnal Dialysis Boosts Kidney Health

By HospiMedica International staff writers
Posted on 29 Oct 2013
Nocturnal home hemodialysis (NHD) improves kidney health as well decreasing the risk of heart disease by restoring impaired coronary endothelial responsiveness, according to a new study.

Researchers at Toronto General Hospital (TGH; Canada) examined 17 patients, which included 6 NHD patients, 6 receiving conventional intermittent hemodialysis (IHD), and five controls that required diagnostic coronary angiography (CA). More...
The IHD patients had been on dialysis for 24 months, receiving three 4-hour sessions per week, while the NHD patients received six 12-hour sessions per week. Following angiography and systemic heparin, the researchers measured drug-induced changes in mean luminal diameter (MLD), expressed as a percentage increase from baseline measurement.

The results showed that coronary endothelial responsiveness is markedly impaired in IHD patients, an effect that is partially normalized with nocturnal hemodialysis. The researchers also found that free-radical scavenging with Vitamin C partially restores endothelial function in IHD, but not NHD or control subjects, suggesting that greater oxidative stress in IHD patients may contribute to the impaired endothelial responsiveness. The study was presented at the Canadian Cardiovascular Congress, held during October 2013 in Montreal (Canada).

“Patients with end-stage renal disease have at least a five-fold increase in cardiovascular complications,” said study coauthor cardiologist Christopher Overgaard, MD. “Longer dialysis done while patients are sleeping may improve the health of arteries and could lower the risk of developing heart disease.”

When patients with accelerated atherosclerosis in end-stage renal disease (ESRD) under an IHD regimen are converted to NHD, they experience a rapid (1-2 months) increase in dialysis dose, restoring both absent brachial artery endothelium-dependent hyperemia and markedly impaired endothelium-independent vasodilatation.

Related Links:

Toronto General Hospital



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Fetal Monitor
BT-380
New
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The new Cora Torqueable Microcatheters expand our coronary portfolio supporting patients with coronary artery disease (photo courtesy of Reflow Medical)

Torqueable Microcatheters Enhance Navigation in Complex Coronary Lesions

Interventional cardiologists frequently encounter tortuous vessels and heavily calcified or fibrotic coronary lesions that complicate guidewire control and device delivery. Stable, predictable torque and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.